A detailed history of Cwm, LLC transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Cwm, LLC holds 1,325 shares of ONCY stock, worth $1,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,325
Previous 1,325 -0.0%
Holding current value
$1,126
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$0.99 - $1.24 $990 - $1,240
-1,000 Reduced 43.01%
1,325 $1,000
Q3 2023

Oct 11, 2023

BUY
$1.98 - $3.24 $4,405 - $7,209
2,225 Added 2225.0%
2,325 $5,000
Q2 2023

Aug 03, 2023

BUY
$1.11 - $2.74 $111 - $274
100 New
100 $0
Q3 2019

Oct 22, 2019

BUY
$0.54 - $1.71 $12 - $39
23 New
23 $0

Others Institutions Holding ONCY

About ONCOLYTICS BIOTECH INC


  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $49.2M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.